(Reuters) - By Ben Hirschler
LONDON, July 6 - AstraZeneca Plc became the latest big drugmaker to bet on the new science of RNA interference on Friday by signing a deal with Britain's Silence Therapeutics Plc worth up to 200 million pounds .
Read more at Reuters.com Mergers News
LONDON, July 6 - AstraZeneca Plc became the latest big drugmaker to bet on the new science of RNA interference on Friday by signing a deal with Britain's Silence Therapeutics Plc worth up to 200 million pounds .
Read more at Reuters.com Mergers News
No comments:
Post a Comment